Stock Price
P/E Ratio
Volume Traded Today
Dividend
52 Week High/low
Acadia Healthcare Co Inc Market Cap
Based on ratings from 17 stock analysts, the Acadia Healthcare Co Inc stock price is expected to increase by 14.13% in 12 months. This is calculated by using the average 12-month stock price forecast for Acadia Healthcare Co Inc. The lowest target is $75 and the highest is $105. Please note analyst price targets are not guaranteed and could be missed completely.
About 17 Wall Street analysts have assignedACHC 10 buy ratings, 7 hold ratings, and 0 sell ratings. This means that analysts expect Acadia Healthcare Co Inc to buy. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on ACHC. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.
These are the latest 20 analyst ratings of ACHC.
|
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
|---|---|---|---|---|
| Sarah James Cantor Fitzgerald | Neutral | $90 | Reiterates | Aug 20, 2024 |
| Sarah James Cantor Fitzgerald | Neutral | $90 | Reiterates | Aug 19, 2024 |
| Pito Chickering Deutsche Bank | Hold | $75 | Maintains | Aug 2, 2024 |
| Sarah James Cantor Fitzgerald | Neutral | $90 | Reiterates | Aug 2, 2024 |
| Sarah James Cantor Fitzgerald | Neutral | $90 | Reiterates | Aug 1, 2024 |
| Andrew Mok Barclays | Overweight | $83 | Maintains | Aug 1, 2024 |
| Sarah James Cantor Fitzgerald | Neutral | $90 | Reiterates | Jul 10, 2024 |
| Sarah James Cantor Fitzgerald | Neutral | $90 | Reiterates | Jul 9, 2024 |
| Sarah James Cantor Fitzgerald | Neutral | $90 | Reiterates | Jul 2, 2024 |
| Ben Hendrix RBC Capital | Outperform | $94 | Reiterates | May 22, 2024 |
| Gary Taylor TD Cowen | Buy | $91 | Maintains | May 17, 2024 |
| Andrew Mok Barclays | Overweight | $89 | Maintains | May 15, 2024 |
| Ann Hynes Mizuho | Neutral | $70 | Maintains | May 3, 2024 |
| Andrew Mok Barclays | Overweight | $91 | Maintains | May 2, 2024 |
| Kevin Fischbeck B of A Securities | Buy | $90 | Maintains | May 2, 2024 |
| Pito Chickering Deutsche Bank | Hold | $70 | Upgrade | Apr 25, 2024 |
| Ann Hynes Mizuho | Neutral | $84 | Maintains | Mar 6, 2024 |
| Andrew Mok Barclays | Overweight | $100 | Initiates | Mar 6, 2024 |
| Sarah James Cantor Fitzgerald | Neutral | $90 | Reiterates | Mar 5, 2024 |
| Ben Hendrix RBC Capital | Outperform | $94 | Reiterates | Mar 4, 2024 |
When did it IPO
N/A
Staff Count
23,500
Country
United States
Sector/Industry
Healthcare/Medical Care Facilities
CEO
Mr. Christopher Howal Hunter
Market Cap
$7.26B
In 2023, ACHC generated $2.93B in revenue, which was a increase of 12.20% from the previous year. This can be seen as a signal that ACHC's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Fri, 13 Sep 2024
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - Rosen Law Firm is investigating Acadia Healthcare (NASDAQ: ACHC) for potential securities claims due to allegations of misleading business information to investors.
Why It Matters - Allegations of misleading information can lead to stock price volatility and potential legal liabilities for Acadia Healthcare, impacting investor confidence and financial performance.
Wed, 11 Sep 2024
Sentiment - NEUTRAL
Source - GlobeNewsWire
Summary - Bronstein, Gewirtz & Grossman, LLC is investigating potential claims for investors of Acadia Healthcare (NASDAQ: ACHC). Affected investors can find more information at bgandg.com/ACHC.
Why It Matters - Investors in Acadia Healthcare may face potential legal claims, which could impact the company's stock price and financial stability, prompting a need for caution and further investigation.
Wed, 11 Sep 2024
Sentiment - NEUTRAL
Source - Accesswire
Summary - The Schall Law Firm is investigating Acadia Healthcare Company (NASDAQ: ACHC) for potential securities law violations, including possible misstatements affecting investors.
Why It Matters - Investors may face potential losses if Acadia Healthcare is found liable for securities law violations, affecting stock value and investor confidence.
Thu, 12 Sep 2024
Sentiment - NEUTRAL
Source - Accesswire
Summary - The Schall Law Firm is investigating Acadia Healthcare Company (NASDAQ: ACHC) for potential securities law violations, including false statements to investors.
Why It Matters - Investors should monitor Acadia Healthcare for potential legal issues, as investigations into misleading statements can impact stock performance and shareholder value.
Fri, 13 Sep 2024
Sentiment - NEUTRAL
Source - Accesswire
Summary - The Schall Law Firm is investigating Acadia Healthcare Company (NASDAQ: ACHC) for potential securities law violations, including false statements and undisclosed information affecting investors.
Why It Matters - The investigation into Acadia Healthcare for potential securities law violations could signal risks for investors, possibly impacting stock performance and leading to financial losses.
Fri, 13 Sep 2024
Sentiment - NEUTRAL
Source - Accesswire
Summary - Pomerantz LLP is investigating claims for investors of Acadia Healthcare Company (NASDAQ: ACHC). Interested parties should contact Danielle Peyton for more information.
Why It Matters - The investigation indicates potential legal issues for Acadia Healthcare, which could impact the company's stock performance and investor returns.
The information that Ticker Nerd provides is general in nature as it has been prepared without taking account of your objectives, financial situation or needs. It is not intended as legal, financial or investment advice and should not be construed or relied on as such. Ticker Nerd is for information purposes only. Ticker Nerd is not responsible for any damages or losses that may occur as a result of reliance on this information. Before making any commitment of a legal or financial nature you should seek advice from a qualified and registered legal practitioner or financial or investment adviser. All content, group, messaging, tweets, newsletter, article, and email created by Ticker Nerd is intended for educational and information purposes only, is not financial, investment, legal or tax advice, and is a restatement, summary or extract of other data and research reports that are widely distributed from sources such as, but not limited to, Bloomberg, Market Watch, Wall Street Journal, Google Finance, and Yahoo Finance. Ticker Nerd is not a registered financial, investment, legal or tax advisor and is not liable for any financial loss you may incur acting on any information provided by Ticker Nerd. By registering, you agree not to hold Ticker Nerd liable at any time or under any circumstances for your decisions, actions, or results.
